The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biobanking Technologies-Global Market Insights and Sales Trends 2024
Synopsis
The global Biobanking Technologies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biobanking Technologies in various end use industries. The expanding demands from the Regenerative Medicine, Life Science and Clinical Research,, are propelling Biobanking Technologies market. Blood Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Tissues segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biobanking Technologies market, driven by demand from China, the second largest economy with some signs of stabilising, the Biobanking Technologies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biobanking Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biobanking Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biobanking Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biobanking Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biobanking Technologies covered in this report include Thermo Fisher, Tecan Group, Qiagen, Hamilton, Brooks Automation, TTP Labtech, VWR, Promega and Worthington, etc.
The global Biobanking Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
Greiner Bio One
Biokryo
Biobank
Biorep
Global Biobanking Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biobanking Technologies market, Segment by Type:
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Global Biobanking Technologies market, by Application
Regenerative Medicine
Life Science
Clinical Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biobanking Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biobanking Technologies market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Biobanking Technologies in various end use industries. The expanding demands from the Regenerative Medicine, Life Science and Clinical Research,, are propelling Biobanking Technologies market. Blood Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Tissues segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biobanking Technologies market, driven by demand from China, the second largest economy with some signs of stabilising, the Biobanking Technologies market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biobanking Technologies, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biobanking Technologies market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biobanking Technologies market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biobanking Technologies sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biobanking Technologies covered in this report include Thermo Fisher, Tecan Group, Qiagen, Hamilton, Brooks Automation, TTP Labtech, VWR, Promega and Worthington, etc.
The global Biobanking Technologies market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Tecan Group
Qiagen
Hamilton
Brooks Automation
TTP Labtech
VWR
Promega
Worthington
Chart Industries
BD
Merck
Micronic
Panasonic
Greiner Bio One
Biokryo
Biobank
Biorep
Global Biobanking Technologies market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biobanking Technologies market, Segment by Type:
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Global Biobanking Technologies market, by Application
Regenerative Medicine
Life Science
Clinical Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biobanking Technologies companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biobanking Technologies
1.1 Biobanking Technologies Market Overview
1.1.1 Biobanking Technologies Product Scope
1.1.2 Biobanking Technologies Market Status and Outlook
1.2 Global Biobanking Technologies Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biobanking Technologies Market Size by Region (2018-2029)
1.4 Global Biobanking Technologies Historic Market Size by Region (2018-2023)
1.5 Global Biobanking Technologies Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biobanking Technologies Market Size (2018-2029)
1.6.1 North America Biobanking Technologies Market Size (2018-2029)
1.6.2 Europe Biobanking Technologies Market Size (2018-2029)
1.6.3 Asia-Pacific Biobanking Technologies Market Size (2018-2029)
1.6.4 Latin America Biobanking Technologies Market Size (2018-2029)
1.6.5 Middle East & Africa Biobanking Technologies Market Size (2018-2029)
2 Biobanking Technologies Market by Type
2.1 Introduction
2.1.1 Blood Products
2.1.2 Human Tissues
2.1.3 Cell Lines
2.1.4 Nucleic Acids
2.2 Global Biobanking Technologies Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biobanking Technologies Historic Market Size by Type (2018-2023)
2.2.2 Global Biobanking Technologies Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biobanking Technologies Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biobanking Technologies Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biobanking Technologies Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biobanking Technologies Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biobanking Technologies Revenue Breakdown by Type (2018-2029)
3 Biobanking Technologies Market Overview by Application
3.1 Introduction
3.1.1 Regenerative Medicine
3.1.2 Life Science
3.1.3 Clinical Research
3.2 Global Biobanking Technologies Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biobanking Technologies Historic Market Size by Application (2018-2023)
3.2.2 Global Biobanking Technologies Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biobanking Technologies Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biobanking Technologies Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biobanking Technologies Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biobanking Technologies Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biobanking Technologies Revenue Breakdown by Application (2018-2029)
4 Biobanking Technologies Competition Analysis by Players
4.1 Global Biobanking Technologies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biobanking Technologies as of 2022)
4.3 Date of Key Players Enter into Biobanking Technologies Market
4.4 Global Top Players Biobanking Technologies Headquarters and Area Served
4.5 Key Players Biobanking Technologies Product Solution and Service
4.6 Competitive Status
4.6.1 Biobanking Technologies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Profile
5.1.2 Thermo Fisher Main Business
5.1.3 Thermo Fisher Biobanking Technologies Products, Services and Solutions
5.1.4 Thermo Fisher Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Recent Developments
5.2 Tecan Group
5.2.1 Tecan Group Profile
5.2.2 Tecan Group Main Business
5.2.3 Tecan Group Biobanking Technologies Products, Services and Solutions
5.2.4 Tecan Group Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.2.5 Tecan Group Recent Developments
5.3 Qiagen
5.3.1 Qiagen Profile
5.3.2 Qiagen Main Business
5.3.3 Qiagen Biobanking Technologies Products, Services and Solutions
5.3.4 Qiagen Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.3.5 Hamilton Recent Developments
5.4 Hamilton
5.4.1 Hamilton Profile
5.4.2 Hamilton Main Business
5.4.3 Hamilton Biobanking Technologies Products, Services and Solutions
5.4.4 Hamilton Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.4.5 Hamilton Recent Developments
5.5 Brooks Automation
5.5.1 Brooks Automation Profile
5.5.2 Brooks Automation Main Business
5.5.3 Brooks Automation Biobanking Technologies Products, Services and Solutions
5.5.4 Brooks Automation Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.5.5 Brooks Automation Recent Developments
5.6 TTP Labtech
5.6.1 TTP Labtech Profile
5.6.2 TTP Labtech Main Business
5.6.3 TTP Labtech Biobanking Technologies Products, Services and Solutions
5.6.4 TTP Labtech Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.6.5 TTP Labtech Recent Developments
5.7 VWR
5.7.1 VWR Profile
5.7.2 VWR Main Business
5.7.3 VWR Biobanking Technologies Products, Services and Solutions
5.7.4 VWR Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.7.5 VWR Recent Developments
5.8 Promega
5.8.1 Promega Profile
5.8.2 Promega Main Business
5.8.3 Promega Biobanking Technologies Products, Services and Solutions
5.8.4 Promega Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.8.5 Promega Recent Developments
5.9 Worthington
5.9.1 Worthington Profile
5.9.2 Worthington Main Business
5.9.3 Worthington Biobanking Technologies Products, Services and Solutions
5.9.4 Worthington Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.9.5 Worthington Recent Developments
5.10 Chart Industries
5.10.1 Chart Industries Profile
5.10.2 Chart Industries Main Business
5.10.3 Chart Industries Biobanking Technologies Products, Services and Solutions
5.10.4 Chart Industries Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.10.5 Chart Industries Recent Developments
5.11 BD
5.11.1 BD Profile
5.11.2 BD Main Business
5.11.3 BD Biobanking Technologies Products, Services and Solutions
5.11.4 BD Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.11.5 BD Recent Developments
5.12 Merck
5.12.1 Merck Profile
5.12.2 Merck Main Business
5.12.3 Merck Biobanking Technologies Products, Services and Solutions
5.12.4 Merck Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.12.5 Merck Recent Developments
5.13 Micronic
5.13.1 Micronic Profile
5.13.2 Micronic Main Business
5.13.3 Micronic Biobanking Technologies Products, Services and Solutions
5.13.4 Micronic Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.13.5 Micronic Recent Developments
5.14 Panasonic
5.14.1 Panasonic Profile
5.14.2 Panasonic Main Business
5.14.3 Panasonic Biobanking Technologies Products, Services and Solutions
5.14.4 Panasonic Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.14.5 Panasonic Recent Developments
5.15 Greiner Bio One
5.15.1 Greiner Bio One Profile
5.15.2 Greiner Bio One Main Business
5.15.3 Greiner Bio One Biobanking Technologies Products, Services and Solutions
5.15.4 Greiner Bio One Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.15.5 Greiner Bio One Recent Developments
5.16 Biokryo
5.16.1 Biokryo Profile
5.16.2 Biokryo Main Business
5.16.3 Biokryo Biobanking Technologies Products, Services and Solutions
5.16.4 Biokryo Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.16.5 Biokryo Recent Developments
5.17 Biobank
5.17.1 Biobank Profile
5.17.2 Biobank Main Business
5.17.3 Biobank Biobanking Technologies Products, Services and Solutions
5.17.4 Biobank Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.17.5 Biobank Recent Developments
5.18 Biorep
5.18.1 Biorep Profile
5.18.2 Biorep Main Business
5.18.3 Biorep Biobanking Technologies Products, Services and Solutions
5.18.4 Biorep Biobanking Technologies Revenue (US$ Million) & (2018-2023)
5.18.5 Biorep Recent Developments
6 North America
6.1 North America Biobanking Technologies Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biobanking Technologies Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biobanking Technologies Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biobanking Technologies Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biobanking Technologies Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biobanking Technologies Market Dynamics
11.1 Biobanking Technologies Industry Trends
11.2 Biobanking Technologies Market Drivers
11.3 Biobanking Technologies Market Challenges
11.4 Biobanking Technologies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
